Comparable stake leader
BlackRock, Inc.
SEC ownership of EXACT SCIENCES CORP
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001124140.
Disclosed value leader
BlackRock, Inc.
Comparable rows
11/24
Latest evidence
31 Mar 2026
- Symbol
- EXAS on Nasdaq
- SEC evidence covered
- 13D/G, 3/4/5, and 13F
- Largest SEC-reported holder
- BlackRock, Inc.
- Latest 13D/G holder
- BlackRock, Inc.
- Latest parsed evidence date
- 31 Mar 2026
- CIK
- 0001124140
- Location
- Madison, WI
Ownership snapshot
2 signals
Issuer
2 identity fields
Ownership snapshot
Top shareholders of EXACT SCIENCES CORP (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
11/24
Latest evidence
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 4.3%
13 rows are not safely comparable across share classes.
13D/G row: BlackRock, Inc.
Showing 1-8 of 24 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 4.3%.
11 of 24 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
BlackRock, Inc.
4.3%
WELLINGTON MANAGEMENT GROUP LLP
3%
FMR LLC
2.9%
Capital World Investors
0.5%
Daniel J. Levangie
0.02%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 24 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
|
4.3%
|
$428,865,998
8,070,493 shares
|
$0 | 30 Jun 2025 |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
|
3%
|
$314,423,458
5,747,093 shares
|
-$363,668,859 | 30 Sep 2025 |
| FMR LLC |
13D/G
|
2.9%
|
$373,106,856
5,507,112 shares
|
-$886,242,560 | 28 Nov 2025 |
| Capital World Investors |
13D/G
|
0.5%
|
$99,001,722
968,232 shares
|
-$1,551,401,315 | 31 Dec 2025 |
| Daniel J. Levangie |
3/4/5
Director
|
0.02%
|
$1,828,143
34,312 shares
|
— | 12 Jun 2025 |
| VAN ECK ASSOCIATES CORP |
13F
Company
|
0.01%
|
$2,194,000
20,917 shares
|
— | 31 Mar 2026 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
Company
|
0.01%
|
$1,204,468
11,481 shares
|
— | 31 Mar 2026 |
| PINKERTON WEALTH, LLC |
13F
Company
|
0.01%
|
$1,064,247
10,479 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$1,973,421.
Buys
$0
Insiders: 0
Sells
$1,973,421
Insiders: 5
Net
-$1,973,421
Shares: -30,550
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 30,550
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 25,858 | $0 | $1,740,409 | -$1,740,409 |
| 9-12 | 0 | 4,692 | $0 | $233,012 | -$233,012 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 22 reporting-owner rows connected to EXACT SCIENCES CORP. Open a relationship link for the CIK-to-CIK filing trail.
Rows
22
Largest Forms 3/4/5 holder
Everett Cunningham
Net 12M change
-$1,973,421
Latest report
23 Mar 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Everett Cunningham | Chief Commercial Officer | $3,805,686 | Mixed | 30 Apr 2024 | ||
| Kevin T. Conroy | President and CEO, Director | $3,180,221 | Mixed | 23 Mar 2026 | ||
| Daniel J. Levangie | Director | $1,828,143 | Mixed | 12 Jun 2025 | ||
| Jeffrey Thomas Elliott | Chief Financial Officer | $1,746,571 | Mixed | 30 Apr 2024 | ||
| Pierre Jacquet | Director | $1,732,836 | Mixed | 08 Jun 2023 | ||
| Aaron Bloomer | EVP, Chief Financial Officer | $1,713,139 | Mixed | 23 Mar 2026 | ||
| Kathleen Sebelius | Director | $1,677,656 | Mixed | 13 Jun 2024 | ||
| Freda Lewis-Hall | Director | $1,447,068 | Mixed | 08 Jun 2023 | ||
| Brian Baranick | EVP, GM, Precision Oncology | $709,888 | -$200,289 | -22% | Mixed | 23 Mar 2026 |
| Jacob A. Orville | EVP, GM, Screening | $709,888 | -$375,000 | -35% | Mixed | 23 Mar 2026 |
| Sarah Condella | EVP, Human Resources | $567,910 | Mixed | 23 Mar 2026 | ||
| Timothy J. Scannell | Director | $418,509 | Mixed | 31 Oct 2023 | ||
| Thomas D. Carey | Director | $388,962 | Mixed | 02 Jun 2021 | ||
| James Herriott | SVP, General Counsel & Sec | $340,718 | -$265,120 | -44% | Mixed | 23 Mar 2026 |
| Paul J. Clancy | Director | $0 | Mixed | 23 Mar 2026 | ||
| D. Scott Coward | Director | $0 | Mixed | 23 Mar 2026 | ||
| Michael J. Barber | Director | $0 | Mixed | 23 Mar 2026 | ||
| Kimberly J. Popovits | Director | $0 | Mixed | 23 Mar 2026 | ||
| Shacey Petrovic | Director | $0 | Mixed | 23 Mar 2026 | ||
| Leslie Trigg | Director | $0 | Mixed | 23 Mar 2026 |
Recent insider transactions for EXACT SCIENCES CORP
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Brian Baranick | EXAS | Common Stock | Disposed to Issuer | -100% | -795 | 0 | 23 Mar 2026 | Held in 401(k) Plan | ||
| Brian Baranick | EXAS | Common Stock | Disposed to Issuer | -100% | -137,195 | 0 | 23 Mar 2026 | Direct | ||
| Brian Baranick | EXAS | Common Stock | Award | 32.1% | 33,321 | 137,195 | 23 Mar 2026 | Direct | ||
| Brian Baranick | EXAS | Restricted Stock Units | Disposed to Issuer | -100% | -28,063 | 0 | 23 Mar 2026 | Direct | ||
| James Herriott | EXAS | Common Stock | Disposed to Issuer | -100% | -1,762 | 0 | 23 Mar 2026 | Held in 401(k) Plan | ||
| James Herriott | EXAS | Common Stock | Disposed to Issuer | -100% | -68,195 | 0 | 23 Mar 2026 | Direct | ||
| James Herriott | EXAS | Restricted Stock Units | Disposed to Issuer | -100% | -20,321 | 0 | 23 Mar 2026 | Direct | ||
| James Herriott | EXAS | Stock Options (Right to Buy) | Disposed to Issuer | -100% | -3,654 | 0 | 23 Mar 2026 | Direct | ||
| Aaron Bloomer | EXAS | Common Stock | Disposed to Issuer | -100% | -417 | 0 | 23 Mar 2026 | Held in 401(k) Plan | ||
| Aaron Bloomer | EXAS | Common Stock | Disposed to Issuer | -100% | -138,679 | 0 | 23 Mar 2026 | Direct | ||
| Aaron Bloomer | EXAS | Common Stock | Award | 184.4% | 89,911 | 138,679 | 23 Mar 2026 | Direct | ||
| Aaron Bloomer | EXAS | Restricted Stock Units | Disposed to Issuer | -100% | -32,458 | 0 | 23 Mar 2026 | Direct | ||
| Sarah Condella | EXAS | Common Stock | Disposed to Issuer | -100% | -6,368 | 0 | 23 Mar 2026 | Held in 401(k) Plan | ||
| Sarah Condella | EXAS | Common Stock | Disposed to Issuer | -100% | -191,891 | 0 | 23 Mar 2026 | Direct | ||
| Sarah Condella | EXAS | Common Stock | Award | 45.9% | 60,389 | 191,891 | 23 Mar 2026 | Direct | ||
| Sarah Condella | EXAS | Restricted Stock Units | Disposed to Issuer | -100% | -23,224 | 0 | 23 Mar 2026 | Direct | ||
| Sarah Condella | EXAS | Stock Options (Right to Buy) | Disposed to Issuer | -100% | -48,019 | 0 | 23 Mar 2026 | Direct | ||
| Conroy Kevin T. | EXAS | Common Stock | Disposed to Issuer | -100% | -250,715 | 0 | 23 Mar 2026 | Held in Grantor Retained Annuity Trust | ||
| Conroy Kevin T. | EXAS | Common Stock | Disposed to Issuer | -100% | -29,061 | 0 | 23 Mar 2026 | Held in 401(k) Plan | ||
| Conroy Kevin T. | EXAS | Common Stock | Disposed to Issuer | -100% | -1,397,738 | 0 | 23 Mar 2026 | Direct | ||
| Conroy Kevin T. | EXAS | Common Stock | Award | 9.33% | 119,312 | 1,397,738 | 23 Mar 2026 | Direct | ||
| Conroy Kevin T. | EXAS | Restricted Stock Units | Disposed to Issuer | -100% | -300,668 | 0 | 23 Mar 2026 | Direct | ||
| Conroy Kevin T. | EXAS | Stock Options (Right to Buy) | Disposed to Issuer | -100% | -436,461 | 0 | 23 Mar 2026 | Direct | ||
| Jacob A. Orville | EXAS | Common Stock | Disposed to Issuer | -100% | -1,774 | 0 | 23 Mar 2026 | Held in 401(k) Plan | ||
| Jacob A. Orville | EXAS | Common Stock | Disposed to Issuer | -100% | -153,726 | 0 | 23 Mar 2026 | Direct | ||
| Jacob A. Orville | EXAS | Common Stock | Award | 53.1% | 53,323 | 153,726 | 23 Mar 2026 | Direct | ||
| Jacob A. Orville | EXAS | Restricted Stock Units | Disposed to Issuer | -100% | -38,707 | 0 | 23 Mar 2026 | Direct | ||
| Jacob A. Orville | EXAS | Stock Options (Right to Buy) | Disposed to Issuer | -100% | -6,581 | 0 | 23 Mar 2026 | Direct | ||
| D. Scott Coward | EXAS | Common Stock | Disposed to Issuer | -100% | -4,694 | 0 | 23 Mar 2026 | Held in 401(k) Plan | ||
| D. Scott Coward | EXAS | Common Stock | Disposed to Issuer | -100% | -57,562 | 0 | 23 Mar 2026 | Direct | ||
| D. Scott Coward | EXAS | Stock Options (Right to Buy) | Disposed to Issuer | -100% | -27,836 | 0 | 23 Mar 2026 | Direct | ||
| Shacey Petrovic | EXAS | Common Stock | Disposed to Issuer | -100% | -7,095 | 0 | 23 Mar 2026 | By grantor retained annuity trust | ||
| Shacey Petrovic | EXAS | Common Stock | Disposed to Issuer | -100% | -21,804 | 0 | 23 Mar 2026 | Direct | ||
| Katherine S. Zanotti | EXAS | Common Stock | Disposed to Issuer | -100% | -60,759 | 0 | 23 Mar 2026 | Direct | ||
| Kimberly J. Popovits | EXAS | Common Stock | Disposed to Issuer | -100% | -16,381 | 0 | 23 Mar 2026 | Direct | ||
| James Edward Doyle | EXAS | Common Stock | Disposed to Issuer | -100% | -57,962 | 0 | 23 Mar 2026 | Direct | ||
| Paul J. Clancy | EXAS | Common Stock | Disposed to Issuer | -100% | -26,038 | 0 | 23 Mar 2026 | Direct | ||
| Michael J. Barber | EXAS | Common Stock | Disposed to Issuer | -100% | -13,136 | 0 | 23 Mar 2026 | Direct | ||
| Michael J. Barber | EXAS | Deferred Stock Units | Disposed to Issuer | -100% | -7,422 | 0 | 23 Mar 2026 | Direct | ||
| Leslie Trigg | EXAS | Common Stock | Disposed to Issuer | -100% | -17,169 | 0 | 23 Mar 2026 | Direct | ||
| Conroy Kevin T. | EXAS | Common Stock | Tax liability | -2.49% | -32,007 | 1,251,570 | 27 Feb 2026 | Direct | ||
| Conroy Kevin T. | EXAS | Common Stock | Options Exercise | 5.57% | 68,097 | 1,291,105 | 27 Feb 2026 | Direct | ||
| Conroy Kevin T. | EXAS | Restricted Stock Units | Options Exercise | -79% | -68,097 | 18,143 | 27 Feb 2026 | Direct | ||
| Sarah Condella | EXAS | Common Stock | Tax liability | -1.44% | -1,913 | 131,121 | 27 Feb 2026 | Direct | ||
| Sarah Condella | EXAS | Common Stock | Options Exercise | 3.02% | 3,900 | 133,034 | 27 Feb 2026 | Direct | ||
| Sarah Condella | EXAS | Stock Options (Right to Buy) | Options Exercise | -100% | -3,900 | 0 | 27 Feb 2026 | Direct | ||
| Sarah Condella | EXAS | Restricted Stock Units | Award | 23,224 | 23,224 | 25 Feb 2026 | Direct | |||
| James Herriott | EXAS | Restricted Stock Units | Award | 20,321 | 20,321 | 25 Feb 2026 | Direct | |||
| Conroy Kevin T. | EXAS | Common Stock | Tax liability | -0.5% | -6,196 | 1,241,955 | 25 Feb 2026 | Direct | ||
| Conroy Kevin T. | EXAS | Common Stock | Award | 1.07% | 13,181 | 1,248,151 | 25 Feb 2026 | Direct |
* marks a reported price that did not pass the local price check.